BFA
NGNE icon

BlackRock Fund Advisors’s Neurogene NGNE Stock Holding History

BlackRock Fund Advisors’s Portfolio NGNE Stock Details NGNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$5.46M Buy
16,537
+4,967
+43% +$1.34M ﹤0.01% 2891
2016
Q3 		$3.09M Buy
11,570
+135
+1% +$27.2K ﹤0.01% 3057
2016
Q2 		$1.51M Buy
11,435
+199
+2% +$31.6K ﹤0.01% 3228
2016
Q1 		$1.98M Buy
11,236
+1,064
+10% +$207K ﹤0.01% 3082
2015
Q4 		$2.54M Buy
+10,172
New +$2.68M ﹤0.01% 3092

Other funds holding NGNE

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

BlackRock Fund Advisors's NGNE Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Neurogene (NGNE) stake by 43% in Q4 2016, buying an estimated $1.34M and bringing the position to 16,537 shares worth $5.46M. The position accounts for ﹤0.01% of the portfolio, ranked #2891.

BlackRock Fund Advisors first reported a position in NGNE in Q4 2015 and has held it in 5 quarters since. 49 funds tracked by Wall St. Rank hold NGNE as of Q4 2016.

  • BlackRock Fund Advisors held 16,537 shares of Neurogene worth $5.46M as of Q4 2016.
  • BlackRock Fund Advisors bought 4,967 Neurogene shares in Q4 2016, an estimated $1.34M.
  • Neurogene made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #2891 holding.
  • BlackRock Fund Advisors first reported a position in Neurogene in Q4 2015 and has held it in 5 quarters since.
  • 49 funds tracked by Wall St. Rank held Neurogene as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.